Long-term efficacy of biologic agents and apremilast in scalp psoriasis: a real-life, cohort study

被引:0
|
作者
Bakirtzi, Katerina [1 ]
Kiritsi, Dimitra [1 ]
Papadimitriou, Ilias [1 ]
Vakirlis, Efstratios [1 ]
Sotiriou, Eleni [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Dept Dermatol 1, Thessaloniki, Greece
关键词
D O I
10.1093/bjd/ljae360.076
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P46
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study
    Megna, Matteo
    Ruggiero, Angelo
    Martora, Fabrizio
    Vallone, Ylenia
    Guerrasio, Gianluca
    Potestio, Luca
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [42] Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients
    Cariti, C.
    Dapavo, P.
    Mastorino, L.
    Ortoncelli, M.
    Siliquini, N.
    Merli, M.
    Avallone, G.
    Giordano, S.
    Fabrizio, R.
    Susca, S.
    Verrone, A.
    Stroppiana, E.
    Quaglino, P.
    Ribero, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (03) : E233 - E235
  • [43] Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
    Kollewe, Katja
    Escher, Claus M.
    Wulff, Dirk U.
    Fathi, Davood
    Paracka, Lejla
    Mohammadi, Bahram
    Karst, Matthias
    Dressler, Dirk
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (05) : 533 - 540
  • [44] Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting
    Katja Kollewe
    Claus M. Escher
    Dirk U. Wulff
    Davood Fathi
    Lejla Paracka
    Bahram Mohammadi
    Matthias Karst
    Dirk Dressler
    Journal of Neural Transmission, 2016, 123 : 533 - 540
  • [45] Long-term, real-world efficacy of infliximab for psoriasis
    Mercieca, L.
    Warren, R. B.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E301 - E301
  • [46] Clinical outcomes with long-term sorafenib treatment: A multicenter, real-life study
    Sacco, R.
    Parodi, S.
    Zolfino, T.
    Saitta, C.
    Marzi, L.
    Simonetti, N.
    Attardo, S.
    Rossa, M.
    Bresci, G.
    Cabibbo, G.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E38 - E38
  • [47] Scalp psoriasis and biologic agents: a comparative study from a tertiary psoriasis referral centre
    Fotiadou, C.
    Lazaridou, E.
    Sotiriou, E.
    Apalla, Z.
    Ioannides, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 9 - 9
  • [48] Active tuberculosis in a cohort of patients with psoriasis on biologic therapy: learnings from real-life medical practice
    Lopez-Trujillo, E.
    Pesque, D.
    Sanchez, F.
    Dominguez, M.
    Gallardo, F.
    Pujol, R. M.
    Ferran, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (09) : E689 - E691
  • [49] Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
    Pierre-Dominique Ghislain
    Jo Lambert
    Xuãn-Lan Lam Hoai
    Tom Hillary
    Pierre-Paul Roquet-Gravy
    Michel de la Brassinne
    Siegfried Segaert
    Advances in Therapy, 2023, 40 : 3279 - 3280
  • [50] Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis
    Carubbi, Francesco
    Fidanza, Rosaria
    Palmieri, Maria
    Ventura, Alessandra
    Tambone, Sara
    Cipriani, Paola
    Giacomelli, Roberto
    Fargnoli, Maria Concetta
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (07) : 692 - 697